Advertisement

---

ORBUSNEICH

OrbusNeich Launches World's First Dual Therapy Stent That Addresses Challenges of Delayed Coronary Artery Healing Associated with Monotherapy Drug Eluting Stents

[2013-05-27] - Company Receives CE Mark for COMBO Dual Therapy Stent™; Introduces Product in Europe and Markets in Asia Pacific and Middle East Regions


Delayed Healing of Coronary Artery Following Implantation of Drug Eluting Stents, Increasing Risk of Thrombosis, is a Top Concern of Interventional Cardiologists, International Survey Shows

[2013-05-21] -


OrbusNeich's Genous™ Stent Associated With Lower Restenosis Rate Compared to Bare Metal Stents in Low-Risk Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Patients

[2013-05-20] - Results of Randomized JACK-EPC Trial Published in Minerva Cardioangiologica


COMBO Dual Therapy Stent™ Clinical Results to Be Featured at EuroPCR 2013

[2013-05-13] - Results Will Be Presented During Symposium "Clinical Value of Anti-Restenosis and Pro-Healing COMBO Stent" and Oral Scientific Sessions


Advertisement
Most read: scientific news

More:

---


---
Follow us...

google plus Facebook twitter Newsletter

---


---

Plan du site

Actualités

Actualités

Actualités

Réglementaire

Emploi

Annuaires

Dictionnaire

Divers